ep 459 has been researched along with calpain in 3 studies
| Studies (ep 459) | Trials (ep 459) | Recent Studies (post-2010) (ep 459) | Studies (calpain) | Trials (calpain) | Recent Studies (post-2010) (calpain) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 7,019 | 25 | 2,422 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, E; Ito, M; Sato, A; Shigeta, S; Takami, Y; Tanabe, F | 1 |
| Aihara, H; Hanada, K; Isogai, K; Shibata, N; Tsuchida, K | 1 |
| Amaya, N; Miyatake, T; Sato, S; Yanagisawa, K | 1 |
3 other study(ies) available for ep 459 and calpain
| Article | Year |
|---|---|
The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak-Higashi syndrome) beige mouse.
Topics: Animals; Calpain; Chediak-Higashi Syndrome; Cysteine Proteinase Inhibitors; Cytotoxicity, Immunologic; Disease Models, Animal; Killer Cells, Natural; Killer Factors, Yeast; Leucine; Leupeptins; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Protein Biosynthesis; Protein Kinase C; Proteins; Tetradecanoylphorbol Acetate | 1989 |
Degradation of myocardial structural proteins in myocardial infarcted dogs is reduced by Ep459, a cysteine proteinase inhibitor.
Topics: Animals; Calpain; Cathepsin B; Cathepsin L; Cathepsins; Coronary Disease; Cysteine Endopeptidases; Dogs; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Female; Kinetics; Leucine; Male; Muscle Proteins; Myocardial Infarction; Myocardium; Protease Inhibitors | 1986 |
Degradation of myelin basic protein by calcium-activated neutral protease (CANP) in human brain and inhibition by E-64 analogue.
Topics: Brain; Calpain; Endopeptidases; Humans; Kinetics; Leucine; Myelin Basic Protein; Protease Inhibitors | 1983 |